MTAP DELETION

Clinical trials for MTAP DELETION explained in plain language.

Never miss a new study

Get alerted when new MTAP DELETION trials appear

Sign up with your email to follow new studies for MTAP DELETION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Hard-to-Treat cancers: targeted combo trial opens

Disease control Recruiting now

This study tests a new oral drug, TNG462, combined with other treatments for people with pancreatic or non-small cell lung cancer that has lost the MTAP gene and, in some cases, has a RAS mutation. The goal is to find safe doses and see if the combinations shrink tumors. About 18…

Matched conditions: MTAP DELETION

Phase: PHASE1, PHASE2 • Sponsor: Tango Therapeutics, Inc. • Aim: Disease control

Last updated May 01, 2026 13:45 UTC

MTAP DELETION

Get alerted when new MTAP DELETION trials appear

New hope for Hard-to-Treat cancers: targeted combo trial opens